Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Revision: 1, Status: Authorised

PSUSA/00010312/202501

Human medicines European public assessment report (EPAR): Zoledronic acid Teva, zoledronic acid, Date of authorisation: 16/08/2012, Revision: 15, Status: Authorised

Innovation Task Force briefing meetings

List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)

Ecalta

Medicine Shortages Single Point of Contact (SPOC) Working Party

Veterinary medicines European public assessment report (EPAR): Equilis EHV 1+4, Equine herpesvirus vaccine (inactivated), Status: Application withdrawn

Human medicines European public assessment report (EPAR): Xaluprine (previously Mercaptopurine Nova Laboratories), mercaptopurine, Date of authorisation: 09/03/2012, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 51, Status: Authorised